Literature DB >> 24222117

Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.

Kiichiroh Nakano1, Yasuhiro Miki, Shuko Hata, Akiko Ebata, Kiyoshi Takagi, Keely M McNamara, Minako Sakurai, Mariko Masuda, Hisashi Hirakawa, Takanori Ishida, Takashi Suzuki, Noriaki Ohuchi, Hironobu Sasano.   

Abstract

BACKGROUND: Androgen receptors (ARs) are expressed in many breast cancer cells, but the mechanism of action of androgens is not as well-characterized as in other cell types. The study of microRNAs has recently provided with important insights into the biology of hormone-dependent cancer.
MATERIALS AND METHODS: We attempted to identify microRNAs induced by dihydrotestosterone in an AR-positive cell line. We examined a possible correlation among microRNAs, target genes, and ARs in breast cancer tissues using immunohistochemistry and laser capture microscopy.
RESULTS: Our analysis demonstrated that miR-363 and its possible target IQ motif and WD repeats-1 (IQWD1) are involved in a microRNA-mRNA pathway related to the mechanism of action of androgens. Our analyses showed that a high tumor level of IQWD1 in patients with breast cancer was significantly associated with adverse clinical outcomes.
CONCLUSION: Our findings indicated that the recruitment of IQWD1 to ARs may be a prerequisite for the growth stimulation by androgens through ARs in breast cancer cells.

Entities:  

Keywords:  Breast cancer; IQWD1; androgen; microRNA

Mesh:

Substances:

Year:  2013        PMID: 24222117

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

Review 2.  Steroid hormones, steroid receptors, and breast cancer stem cells.

Authors:  Jessica Finlay-Schultz; Carol A Sartorius
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-08-12       Impact factor: 2.673

3.  NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.

Authors:  Hsin-Hsiung Chen; Ping Fan; Szu-Wei Chang; Yeou-Ping Tsao; Hsiang-Po Huang; Show-Li Chen
Journal:  Oncotarget       Date:  2017-03-28

Review 4.  Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis.

Authors:  Julia Jansen; Thomas Greither; Hermann M Behre
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

Review 5.  Targeting androgen receptor signaling with MicroRNAs and Curcumin: a promising therapeutic approach for Prostate Cancer Prevention and intervention.

Authors:  Zeeshan Javed; Khushbukhat Khan; Amna Rasheed; Haleema Sadia; Muhammad Naeem Shahwani; Asma Irshad; Shahid Raza; Bahare Salehi; Javad Sharifi-Rad; Hafiz A R Suleria; Natália Cruz-Martins; Cristina Quispe
Journal:  Cancer Cell Int       Date:  2021-01-26       Impact factor: 5.722

Review 6.  Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer.

Authors:  Amal Qattan; Taher Al-Tweigeri; Kausar Suleman
Journal:  Biomedicines       Date:  2022-02-02

Review 7.  Androgen receptor in breast cancer: The "5W" questions.

Authors:  Sara Ravaioli; Roberta Maltoni; Barbara Pasculli; Paola Parrella; Anna Maria Giudetti; Daniele Vergara; Maria Maddalena Tumedei; Francesca Pirini; Sara Bravaccini
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

8.  Differential microRNA expression is associated with androgen receptor expression in breast cancer.

Authors:  Yaqin Shi; Fang Yang; Zijia Sun; Wenwen Zhang; Jun Gu; Xiaoxiang Guan
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

9.  Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.

Authors:  Xin Wang; Tianyi Qian; Siqi Bao; Hengqiang Zhao; Hongyan Chen; Zeyu Xing; Yalun Li; Menglu Zhang; Xiangzhi Meng; Changchang Wang; Jie Wang; Hongxia Gao; Jiaqi Liu; Meng Zhou; Xiang Wang
Journal:  Mol Oncol       Date:  2021-06-25       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.